136 related articles for article (PubMed ID: 7980759)
1. Roxithromycin and lower respiratory tract infections.
Scott WG; Cooper BC; Scott HM; Karalus NC; Garrett J; Lang SD
N Z Med J; 1994 May; 107(978):208. PubMed ID: 7980759
[No Abstract] [Full Text] [Related]
2. Roxithromycin vs amoxycillin/clavulanic acid in lower respiratory tract infections.
Brett W
N Z Med J; 1994 Aug; 107(983):319-20. PubMed ID: 8052477
[No Abstract] [Full Text] [Related]
3. Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study.
Scott WG; Cooper BC; Scott HM
Infection; 1995; 23 Suppl 1():S21-4. PubMed ID: 7782111
[TBL] [Abstract][Full Text] [Related]
4. Roxithromycin versus amoxicillin-clavulanic acid in the treatment of respiratory tract infections.
Lousbergh D; Jochems G; Everaert L; Puttemans M
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):91S-95S. PubMed ID: 1617931
[TBL] [Abstract][Full Text] [Related]
5. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Lim TK
Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388
[No Abstract] [Full Text] [Related]
6. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
7. Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice.
Karalus NC; Garrett JE; Lang SD; Leng RA; Kostalas GN; Cursons RT; Cooper BC; Ryan CJ
Infection; 1995; 23 Suppl 1():S15-20. PubMed ID: 7782110
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of antibiotic prophylaxis of wound infection.
Davey PG
J Chemother; 1994 Apr; 6 Suppl 2():29-33. PubMed ID: 7799052
[TBL] [Abstract][Full Text] [Related]
9. [Augmentin--current and prospective therapeutic indications].
Mihălţan F
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
[No Abstract] [Full Text] [Related]
10. [Therapy of pulmonary bacterial infections with amoxicillin and clavulanic acid: clinical experience].
Bisetti A; Grassi L; Romano V; Scacciavillani E
Arch Monaldi Mal Torace; 1987; 42(6):505-17. PubMed ID: 3334114
[No Abstract] [Full Text] [Related]
11. [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].
Caramia M; Taddei G; Nobilini A
Minerva Pediatr; 1990; 42(1-2):29-34. PubMed ID: 2186263
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections].
Music E; Kumelj M; Prlja D; Paulin A; Potokar T
Plucne Bolesti; 1989; 41(3-4):187-92. PubMed ID: 2636405
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of infective respiratory diseases with a shielded beta-lactam antibiotic (amoxicillin and clavulanic acid)].
Palermo B; Rizza S; Pistorio MP; Crimi N; Maccarrone C; Mistretta A
Arch Monaldi Mal Torace; 1987; 42(6):519-33. PubMed ID: 3334115
[No Abstract] [Full Text] [Related]
14. Augmentin for urinary tract infections.
Bailey RR
N Z Med J; 1992 Mar; 105(929):90. PubMed ID: 1545949
[No Abstract] [Full Text] [Related]
15. Comparison of two oral antibiotics, roxithromycin and amoxicillin plus clavulanic acid, in lower respiratory tract infections.
Dautzenberg B; Scheimberg A; Brambilla C; Camus P; Godard P; Guerin JC; Lemarie E; Rezvani Y; Rosembaum M; Tuchais E
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):85S-89S. PubMed ID: 1617930
[TBL] [Abstract][Full Text] [Related]
16. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
File TM
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151
[TBL] [Abstract][Full Text] [Related]
17. [Clavulanic acid-shielded amoxicillin in the treatment of acute and chronic infective diseases of the pulmonary system].
Micillo E; Dericoloso A; Tranchese D; Cione P
Arch Monaldi Mal Torace; 1987; 42(6):535-49. PubMed ID: 3334116
[No Abstract] [Full Text] [Related]
18. Efficacy of twice-daily amoxycillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children.
Cook RC; Zachariah J; Cree F; Harrison HE
Br J Clin Pract; 1996; 50(3):125-8. PubMed ID: 8733329
[TBL] [Abstract][Full Text] [Related]
19. [Comparative research on Augmentin].
Robinson OP
Antibiot Khimioter; 1992 Sep; 37(9):9-11. PubMed ID: 1444674
[No Abstract] [Full Text] [Related]
20. A pharmacoeconomic comparison of amoxicillin/clavulanate and cefpodoxime proxetil in the treatment of acute otitis media.
Landholt TF; Kotschwar TR
Clin Ther; 1994; 16(2):327-33; discussion 271-2. PubMed ID: 8062326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
